Скачать или смотреть Facing cGVHD after transplant?

Facing chronic graft-versus-host disease (cGVHD) after a stem cell transplant can be challenging.
💡 Rezurock® (belumosudil) offers a once-daily oral treatment for adults and adolescents (≥12 years) who have tried two or more systemic therapies without success.

🔬 How it works:
👉 Selectively inhibits ROCK2, helping rebalance immune responses and limit tissue fibrosis.
✨ Key Features
✅ Once-daily oral tablet (200 mg)
✅ Targets the ROCK2 pathway to help regulate the immune system and reduce fibrosis
✅ Designed to help patients who have not responded to other treatments

⚠️ This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.

#Rezurock #Belumosudil #cGVHD #GVHD #ChronicGVHD #BMT #HSCT #StemCellTransplant #TransplantMedicine #Immunology #HemOnc #Oncology #RareDisease #CellTherapy #ROCK2Inhibitor #TargetedTherapy #Immunomodulator #AntiFibrotic #SecondLineTherapy #OrphanDrug #BreakthroughTherapy #HopeForPatients #medicinewholesale #medicinewholesaledistributor
#ChinaMedicineWholesaler
#HongKongDrugWholesaleDistributor
#ChinaDrugImportandExportWholesaler
#HongKongPharmaceuticaldistributor
#HongKongDengYueMedicine
#HongKongPharmaceuticaldistributor